Crescita Therapeutics (TSE:CTX) Shares Down 8.2% – Should You Sell?

Crescita Therapeutics Inc. (TSE:CTX) shares fell 8.2% on Thursday . The stock traded as low as C$0.45 and last traded at C$0.45. 100,878 shares were traded during mid-day trading, an increase of 162% from the average session volume of 38,452 shares. The stock had previously closed at C$0.49.

Crescita Therapeutics Stock Performance

The company has a debt-to-equity ratio of 5.77, a current ratio of 2.70 and a quick ratio of 2.29. The company has a market cap of C$8.56 million, a PE ratio of 23.00 and a beta of -0.26. The business has a fifty day simple moving average of C$0.48 and a two-hundred day simple moving average of C$0.47.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.